Enjoy FREE shipping on your first order! (Minimum $99 purchase)
*The product shipped may have different packaging depending on supplier/strength chosen
Incruse Ellipta Inhaler offers relief from chronic obstructive pulmonary disease. Curious about knowing the Incruse Ellipta Inhaler price? Find cost-effective solutions for managing COPD symptoms efficiently.
Incruse Ellipta is a brand-name medication used for the treatment of Chronic Obstructive Pulmonary Disease (COPD). It comes in the form of an inhaler, specifically the Ellipta inhaler device, which is designed to deliver the medication directly to the lungs for maximum effectiveness.
The active ingredient in Incruse Ellipta is called "Umeclidinium Bromide". Umeclidinium bromide is an anticholinergic medication that helps relax the muscles around the airways in the lungs, making breathing easier. It is classified as a long-acting muscarinic antagonist (LAMA).
Incruse Ellipta inhaler is a dry powder inhaler device that contains blister strips with pre-measured doses of umeclidinium bromide. The inhaler is designed for once-daily use, delivering a consistent dose of the medication to provide ongoing relief from COPD symptoms. CanadaPharmacyPro offers the best Incruse Ellipta Inhaler cost, so check our website to get exciting offers.
Therapeutic Classification: Anticholinergic Bronchodilator.
More specifically, it is a Long-Acting Muscarinic Antagonist (LAMA) bronchodilator. This classification is based on its mechanism of action its intended use for the management of chronic obstructive pulmonary disease (COPD) and its role in relaxing and widening the airways in the lungs to improve breathing.
Incruse Ellipta inhaler is available in the following strength: 62.5 mcg (micrograms) Umeclidinium Bromide per inhalation . Please note that medication formulations and availability can change over time.
To obtain the most current and accurate information about the available strengths of the Incruse Ellipta inhaler, it's best to consult a healthcare professional, or pharmacist, or refer to the manufacturer's official prescribing information.
Incruse Ellipta inhaler, which contains the active ingredient Umeclidinium Bromide, is primarily prescribed for the management of chronic obstructive pulmonary disease (COPD). COPD is a progressive lung disease that includes conditions such as chronic bronchitis and emphysema.
Incruse Ellipta helps improve airflow and makes breathing easier by acting as a bronchodilator, specifically a long-acting muscarinic antagonist (LAMA). It is not typically prescribed for other medical conditions aside from COPD.
The medication works by relaxing the muscles around the airways in the lungs, reducing constriction and allowing for improved airflow. You can get a reasonable Incruse Ellipta Inhaler cost at CanadaPharmacyPro.
The recommended dose for Incruse Ellipta inhaler for the maintenance treatment of chronic obstructive pulmonary disease (COPD) is generally one inhalation (62.5 mcg) once daily.
It's important to follow your healthcare provider's specific instructions for dosing. They will determine the appropriate dosage based on your condition, medical history, and other factors. Do not adjust your dose without consulting your healthcare professional.
Incruse Ellipta inhaler is a long-acting medication, and it is intended for regular use to help manage COPD symptoms over time. If you have any questions about your prescribed dose or how to use the inhaler properly, be sure to ask your healthcare provider or pharmacist for clarification.
Incruse Ellipta inhaler is administered via the inhaled route. It is designed to deliver the medication directly into the lungs to provide effective treatment for chronic obstructive pulmonary disease (COPD).
The inhaler is used to inhale the dry powder form of the medication, allowing it to be absorbed into the respiratory system and provide bronchodilation to improve airflow and alleviate COPD symptoms.
To use the Incruse Ellipta inhaler, place the mouthpiece in your mouth and inhale the powder, ensuring that it reaches your lungs. Always follow the specific instructions provided by your healthcare provider or on the medication packaging for the correct administration technique.
If you have any doubts or concerns about using the inhaler correctly, it's important to consult your healthcare professional or pharmacist. You can buy Incruse Ellipta Inhaler online from CanadaPharmacyPro.
Common side effects of Incruse Ellipta inhaler may include:
Here are some potential drug interactions to be aware of:
Contraindications for Incruse Ellipta include:
While Incruse Ellipta is generally well-tolerated, here are some precautions and recommendations:
If you are considering to buy Incruse Ellipta Inhaler online or any other drug online, it is vital to be careful and only buy from reputable pharmacies like CanadaPharmacyPro. It is also suggested to talk to a licensed doctor before purchasing any drug. Suppose you are looking to purchase Incruse Ellipta Inhaler or any prescription drugs from an Online Pharmacy worldwide.
In that case, you may order from a safe and accredited international pharmacy like CanadaPharmacyPro that offers the best possible Incruse Ellipta Inhaler price. CanadaPharmacyPro offers the best Incruse Ellipta Inhaler cost and a good quality medication as well.
No, the Incruse Ellipta inhaler (Umeclidinium Bromide) is not a steroid. It is an anticholinergic medication that works as a long-acting bronchodilator. Specifically, it is classified as a Long-Acting Muscarinic Antagonist (LAMA).
Generally, you may start to feel some improvement in your breathing within a short period after using the inhaler, usually within 15 to 30 minutes. However, the full bronchodilator effect of Incruse Ellipta may take a few days to a couple of weeks to become noticeable.
Fatigue is not a commonly reported side effect of Incruse Ellipta, but like any medication, individual responses can vary. While some people may experience tiredness or fatigue as a side effect, it's not a universal occurrence.
Incruse Ellipta is not indicated for the treatment of asthma. Incruse Ellipta is primarily approved for the maintenance treatment of Chronic Obstructive Pulmonary Disease (COPD), which includes conditions such as Chronic Bronchitis and Emphysema.
Hair loss is not a commonly reported side effect of Incruse Ellipta. The official prescribing information for Incruse Ellipta does not list hair loss as a known side effect.
DISCLAIMER: The information contained in this page is supplied to canadapharmacypro.com by third party medical content expert, and is not intended to substitute medical advice from a licensed doctor. Always make sure to consult with a doctor before ordering medication online. Do not avoid or delay seeing a healthcare provider based on what you read here.
Please note that not all products, including any referenced in this page, are shipped by our affiliated Canadian Pharmacy. We affiliate with other dispensing pharmacies, that ship product directly to our customers from the following jurisdictions: Australia, New Zealand, Mauritius, India, Canada and United Kingdom. The items in your order may be split and shipped from any other pharmacy that is listed if it is not available from the chosen pharmacy. In this event, you will be contacted and approval obtained before it is shipped. Rest assured, we only affiliate with our authorized dispensaries that procure product through reliable sources.
We will call your doctor for your prescription free of charge.
Submit your doctor details